Anticarcinoma antibodies and uses thereof

Details for Australian Patent Application No. 2004293502 (hide)

Owner Ottawa Health Research Institute National Research Council of Canada

Inventors Mai, Kien, Trung; Zhang, Jianbing; MacKenzie, Colin Roger; Nguyen, Thanh-Dung; Li, Qinggang

Agent Halfords IP

Pub. Number AU-B-2004293502

PCT Pub. Number WO2005/052158

Priority 60/525,183 28.11.03 US

Filing date 17 August 2004

Wipo publication date 9 June 2005

Acceptance publication date 2 December 2010

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/052158 Priority application(s): WO2005/052158

18 November 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Anticarcinoma antibodies and uses thereof 2004311389 Trans World New York, LLC The nature of the amendment is as shown in the statement(s) filed 08 Jul 2010 2005

2 December 2010 Application Accepted

  Published as AU-B-2004293502

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293503-Stabilizers for titanium diboride-containing cathode structures

2004293501-Process for recovering polyhydroxialkanoates ("PHAs") from cellular biomass